Procollagen Assays in Cancer
Authors:
- Leila RisteliLRLeila Risteli
- Marja-Kaisa KoivulaMKMarja-Kaisa Koivula
- Juha RisteliJRJuha Risteli
- 19 August 2014
- book chapter
- Published by Elsevier
- Vol. 66, 79-100
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- The scavenger endothelial cell: a new player in homeostasis and immunityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Measurement of aminoterminal propeptide of type I procollagen (PINP) in serumClinical Biochemistry, 2012
- Consensus on the utility of bone markers in the malignant bone disease settingCritical Reviews in Oncology/Hematology, 2011
- Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assayClinical Biochemistry, 2010
- Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directionsCancer Treatment Reviews, 2008
- Cancer as an overhealing wound: an old hypothesis revisitedNature Reviews Molecular Cell Biology, 2008
- Cancers as Wounds that Do Not Heal: Differences and Similarities between Renal Regeneration/Repair and Renal Cell CarcinomaCancer Research, 2006
- Products of Bone Collagen Metabolism2006
- Fibrillar collagen: The key to vertebrate evolution? A tale of molecular incestBioEssays, 2003
- Collagen family of proteinsThe FASEB Journal, 1991